Toggle navigation
Home
Search
Services
Blog
Contact
About
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail
Protein Sciences Corporation, Meriden, CT, United States
Search 21 grants from Gail Smith
Search grants from Protein Sciences Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Epidermal growth factor mitigates radiation-induced hematopoietic failure
The Role of STRAD-alpha in Cortical Development
Preventing HIV Infection in Women: Targeting Antiretrovirals to Mucosal Tissues
Analytical
Mapping Down Syndrome Phenotypes
Recently added grants:
Structural Requirements for Sterol 14alpha-Demethylases
Inflammatory Gene Transcription in the Retina
Representation of Familiar Images in Ventral Stream Visual Cortex
Transcriptional regulators of iris muscle cell development
OCT in the Ocular Hypertension Treatment Study: 20 Year Follow-up
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI085333-000
Application #
2711335
Study Section
Project Start
1997-12-19
Project End
Budget Start
1997-12-19
Budget End
1998-04-18
Support Year
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Protein Sciences Corporation
Department
Type
DUNS #
City
Meriden
State
CT
Country
United States
Zip Code
06450
Related projects
NIH 1998
N01 AI
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail / Protein Sciences Corporation
NIH 1998
N01 AI
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail / Protein Sciences Corporation
Comments
Be the first to comment on this grant